Klox Technologies Inc a Canada-based regenerative medicine company focused on the development and commercialisation of its proprietary fluorescent light energy biomodulation System (FB System) in dermatology, wound care, and animal health, announced yesterday that it has named Domenic Serafino and Dr Richard Markoff as its new directors.
Serafino is a medical device veteran, with more than 25 years of experience. Presently, he serves as chairman and CEO of Venus Concept with direct operations in 27 of these markets and over 500 employees. He brings extensive experience in sales, marketing and global operations.
Dr Markoff has more than 25 years' experience as a supply chain executive. He is co-founder and partner at Innovobot and earlier managed Global Supply Chain Standards at L'Oreal cosmetics. He holds a PhD in Supply Chain Management and is a lecturer and researcher at Ecole polytechnique federale de Lausanne and the International Institute for Management Development in Switzerland.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business